Xenetic Biosciences, Inc.
XBIO
$3.28
$0.196.15%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 3.19M | 2.98M | 2.86M | 2.45M | 2.58M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.19M | 2.98M | 2.86M | 2.45M | 2.58M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 3.19M | 2.98M | 2.86M | 2.45M | 2.58M |
| SG&A Expenses | 2.74M | 2.75M | 2.84M | 2.77M | 3.24M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.58M | 5.81M | 6.17M | 5.71M | 6.46M |
| Operating Income | -2.39M | -2.83M | -3.31M | -3.27M | -3.88M |
| Income Before Tax | -2.23M | -2.68M | -3.16M | -3.08M | -3.67M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.23 | -2.68 | -3.16 | -3.08 | -3.67 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.23M | -2.68M | -3.16M | -3.08M | -3.67M |
| EBIT | -2.39M | -2.83M | -3.31M | -3.27M | -3.88M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -1.24 | -1.63 | -2.05 | -2.00 | -2.38 |
| Normalized Basic EPS | -0.78 | -1.02 | -1.28 | -1.25 | -1.49 |
| EPS Diluted | -1.24 | -1.63 | -2.05 | -2.00 | -2.38 |
| Normalized Diluted EPS | -0.78 | -1.02 | -1.28 | -1.25 | -1.49 |
| Average Basic Shares Outstanding | 7.56M | 6.81M | 6.17M | 6.17M | 6.17M |
| Average Diluted Shares Outstanding | 7.56M | 6.81M | 6.17M | 6.17M | 6.17M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |